MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-22-2026
Quest Diagnostics Incorporated Operating Cash Flow 2011-2026 | DGX
Annual Operating Cash Flow Quest Diagnostics Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.89 B | 1.33 B | 1.27 B | 1.72 B | 2.23 B | 2 B | 1.24 B | 1.2 B | 1.18 B | 1.12 B | 821 M | 944 M | 652 M | 1.19 B | 895 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.23 B | 652 M | 1.31 B |
Quarterly Operating Cash Flow Quest Diagnostics Incorporated
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 278 M | - | - | 314 M | - | - | 154 M | - | - | 94 M | - | 1.38 B | - | 480 M | - | 1.75 B | - | 731 M | - | 1.46 B | 602 M | 247 M | - | 895 M | 596 M | 275 M | - | 905 M | 503 M | 180 M | - | 852 M | 490 M | 196 M | - | 765 M | 464 M | 153 M | - | 549 M | 337 M | 52 M | - | 635 M | 364 M | 84 M | - | 442 M | 255 M | 47 M | - | 807 M | 412 M | 161 M | - | 558 M | 220 M | 161 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.75 B | 47 M | 496 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 17.56 | -5.39 % | $ 186 M |  China |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 1.46 | -10.44 % | $ 1.94 M |  USA |
 |
Agilent Technologies
A
|
1.48 B | $ 112.25 | -0.88 % | $ 34.1 B | USA |
 |
Castle Biosciences
CSTL
|
64.3 M | $ 18.84 | -0.21 % | $ 546 M | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 16.07 | -0.74 % | $ 486 M | USA |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
837 M | $ 140.65 | -1.81 % | $ 22.4 B | USA |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 20.22 | -1.32 % | $ 1.08 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 94.75 | -1.99 % | $ 6.39 B | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 418.79 | -0.09 % | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 047.48 | 0.53 % | $ 21.6 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 3.63 | 0.14 % | $ 336 M | USA |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
5.23 M | $ 8.26 | -1.2 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 18.68 | -1.32 % | $ 418 M | USA |
 |
Natera
NTRA
|
-432 M | $ 188.85 | -4.1 % | $ 18.6 B | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 159.21 | 0.06 % | $ 7.89 B | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
-185 M | $ 96.67 | -2.02 % | $ 12.1 B | USA |
 |
Personalis
PSNL
|
-74.9 M | $ 6.5 | -3.13 % | $ 580 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 118.02 | 0.79 % | $ 9.73 B |  Irlanda |
 |
Senseonics Holdings
SENS
|
-59.1 M | $ 5.86 | 0.6 % | $ 245 M | USA |
 |
Soleno Therapeutics
SLNO
|
46.8 M | $ 52.98 | -0.02 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.31 | -4.04 % | $ 5.31 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 251.49 | -1.03 % | $ 20.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.82 B | $ 441.01 | -1.61 % | $ 166 B | USA |
 |
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.6 | 3.48 % | $ 216 M | Irlanda |
 |
Celcuity
CELC
|
-153 M | $ 136.61 | 1.4 % | $ 6.39 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 49.96 | -5.65 % | $ 2.99 B | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 8.35 | -1.01 % | $ 1.81 B | USA |